State 1(T) inhibitors of activated Ras

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Ras proteins are key regulators of cell signaling, and their mutations drive approximately 30% of human cancers.
• Ras activation is a transient process involving GTP binding and interaction with effector proteins like Raf kinase.

Purpose of the Study:

• To investigate small molecules that stabilize inactive Ras protein conformations, thereby inhibiting oncogenic signaling.
• To explore the mechanism of action for metal-cyclens and Zn(2+)-BPA in modulating Ras activity.

Main Methods:

• Utilized small molecules, including metal-cyclens and Zn(2+)-BPA, to target Ras protein conformations.
• Analyzed the binding sites and allosteric effects of these molecules on Ras-GTP complex states.
• Compared the affinity of compounds for oncogenic Ras mutants versus wild-type Ras.

Main Results:

• Metal-cyclens bind within the nucleotide-binding pocket, stabilizing the effector-incompetent Ras state 1(T).
• Zn(2+)-BPA allosterically stabilizes Ras state 1(T) by binding outside the nucleotide pocket, inhibiting Raf interaction.
• Zn(2+)-BPA demonstrated higher affinity for the oncogenic Ras(G12V) mutant compared to wild-type Ras.

Conclusions:

• Stabilizing the inactive Ras state 1(T) with small molecules is a viable strategy to interrupt oncogenic Ras signaling.
• Different small molecules, like metal-cyclens and Zn(2+)-BPA, employ distinct binding mechanisms to achieve Ras pathway inhibition.
• Targeting specific Ras conformations offers potential for developing novel cancer therapeutics.